554
Views
6
CrossRef citations to date
0
Altmetric
Research Article

Oral subchronic immunotoxicity study of ethyl tertiary butyl ether in the rat

, , &
Pages 298-304 | Received 05 May 2011, Accepted 16 Jun 2011, Published online: 10 Aug 2011

Figures & data

Table 1.  Body weight (g) and organ weights (mg) in female Crl:CD(SD) rats exposed to ethyl tertiary butyl ether (ETBE) for 28 days.

Table 2.  Spleen antibody-forming cell response to T-dependent antigen sheep erythrocytes (SRBC) in female Crl:CD(SD) rats exposed to ethyl tertiary butyl ether (ETBE) for 28 days.

Figure 1.  Individual IgM antibody-forming cell responses to sheep erythrocytes in female Crl:CD (SD) rats exposed to ETBE via oral gavage for 28 days—Day 4 response. Results of AFC response expressed as individual animal values for specific activity (AFC/106 spleen cells; left panel) or as total spleen activity (AFC/spleen; right panel). N = 10 rats/exposure level for 0, 250, 500, and 1000 mg ETBE/kg/day and 50 mg CPS/kg/day (study Days 24–27).

Figure 1.  Individual IgM antibody-forming cell responses to sheep erythrocytes in female Crl:CD (SD) rats exposed to ETBE via oral gavage for 28 days—Day 4 response. Results of AFC response expressed as individual animal values for specific activity (AFC/106 spleen cells; left panel) or as total spleen activity (AFC/spleen; right panel). N = 10 rats/exposure level for 0, 250, 500, and 1000 mg ETBE/kg/day and 50 mg CPS/kg/day (study Days 24–27).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.